The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Cytoxan     N,N-bis(2-chloroethyl)-2-oxo- 1-oxa-3-aza...

Synonyms: Endoxon, monohydrate, Endoxan A, Prestwick_137, SureCN6071, ...
This record was replaced with 2907.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of cyclophosphamide


Psychiatry related information on cyclophosphamide


High impact information on cyclophosphamide


Chemical compound and disease context of cyclophosphamide


Biological context of cyclophosphamide


Anatomical context of cyclophosphamide


Associations of cyclophosphamide with other chemical compounds


Gene context of cyclophosphamide


Analytical, diagnostic and therapeutic context of cyclophosphamide


  1. Epithelial ovarian cancer: prevention, diagnosis, and treatment. Partridge, E.E., Barnes, M.N. CA: a cancer journal for clinicians. (1999) [Pubmed]
  2. Combination chemotherapy as an adjuvant treatment in operable breast cancer. Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., Veronesi, U. N. Engl. J. Med. (1976) [Pubmed]
  3. Delayed cystitis due to cyclophosphamide. Armstrong, B., Resnick, M.I., Richards, F. N. Engl. J. Med. (1979) [Pubmed]
  4. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. Chan, T.M., Li, F.K., Tang, C.S., Wong, R.W., Fang, G.X., Ji, Y.L., Lau, C.S., Wong, A.K., Tong, M.K., Chan, K.W., Lai, K.N. N. Engl. J. Med. (2000) [Pubmed]
  5. Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow. Phillips, G.L., Herzig, R.H., Lazarus, H.M., Fay, J.W., Wolff, S.N., Mill, W.B., Lin, H., Thomas, P.R., Glasgow, G.P., Shina, D.C. N. Engl. J. Med. (1984) [Pubmed]
  6. Tumor latency in avian lymphoid leukosis. Fadly, A.M., Purchase, H.G., Gilmour, D.G. J. Natl. Cancer Inst. (1981) [Pubmed]
  7. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Bruns, F.J., Adler, S., Fraley, D.S., Segel, D.P. Ann. Intern. Med. (1991) [Pubmed]
  8. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. McSweeney, P.A., Nash, R.A., Sullivan, K.M., Storek, J., Crofford, L.J., Dansey, R., Mayes, M.D., McDonagh, K.T., Nelson, J.L., Gooley, T.A., Holmberg, L.A., Chen, C.S., Wener, M.H., Ryan, K., Sunderhaus, J., Russell, K., Rambharose, J., Storb, R., Furst, D.E. Blood (2002) [Pubmed]
  9. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Kopper, L., Steel, G.G. Cancer Res. (1975) [Pubmed]
  10. Electroconvulsive therapy and cyclophosphamide in combination for severe neuropsychiatric lupus with catatonia. Fricchione, G.L., Kaufman, L.D., Gruber, B.L., Fink, M. Am. J. Med. (1990) [Pubmed]
  11. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Schmitt, C.A., Fridman, J.S., Yang, M., Lee, S., Baranov, E., Hoffman, R.M., Lowe, S.W. Cell (2002) [Pubmed]
  12. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. Stadtmauer, E.A., O'Neill, A., Goldstein, L.J., Crilley, P.A., Mangan, K.F., Ingle, J.N., Brodsky, I., Martino, S., Lazarus, H.M., Erban, J.K., Sickles, C., Glick, J.H. N. Engl. J. Med. (2000) [Pubmed]
  13. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. Cassileth, P.A., Harrington, D.P., Appelbaum, F.R., Lazarus, H.M., Rowe, J.M., Paietta, E., Willman, C., Hurd, D.D., Bennett, J.M., Blume, K.G., Head, D.R., Wiernik, P.H. N. Engl. J. Med. (1998) [Pubmed]
  14. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. Link, M.P., Shuster, J.J., Donaldson, S.S., Berard, C.W., Murphy, S.B. N. Engl. J. Med. (1997) [Pubmed]
  15. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, C.A., Miller, T.P. N. Engl. J. Med. (1993) [Pubmed]
  16. Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. Fauci, A.S., Haynes, B.F., Costa, J., Katz, P., Wolff, S.M. N. Engl. J. Med. (1982) [Pubmed]
  17. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. Duffner, P.K., Horowitz, M.E., Krischer, J.P., Friedman, H.S., Burger, P.C., Cohen, M.E., Sanford, R.A., Mulhern, R.K., James, H.E., Freeman, C.R. N. Engl. J. Med. (1993) [Pubmed]
  18. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. Fefer, A., Cheever, M.A., Thomas, E.D., Boyd, C., Ramberg, R., Glucksberg, H., Buckner, C.D., Storb, R. N. Engl. J. Med. (1979) [Pubmed]
  19. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. Levine, M.N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M.D., Hryniuk, W., De Pauw, S. N. Engl. J. Med. (1988) [Pubmed]
  20. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. O'Reilly, R.J., Dupont, B., Pahwa, S., Grimes, E., Smithwick, E.M., Pahwa, R., Schwartz, S., Hansen, J.A., Siegal, F.P., Sorell, M., Svejgaard, A., Jersild, C., Thomsen, M., Platz, P., L'Esperance, P., Good, R.A. N. Engl. J. Med. (1977) [Pubmed]
  21. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. Nilsson, I.M., Berntorp, E., Zettervall, O. N. Engl. J. Med. (1988) [Pubmed]
  22. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. Look, A.T., Hayes, F.A., Nitschke, R., McWilliams, N.B., Green, A.A. N. Engl. J. Med. (1984) [Pubmed]
  23. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Ikeda, K., Ichikawa, T., Wakimoto, H., Silver, J.S., Deisboeck, T.S., Finkelstein, D., Harsh, G.R., Louis, D.N., Bartus, R.T., Hochberg, F.H., Chiocca, E.A. Nat. Med. (1999) [Pubmed]
  24. Immunologic inhibition of ultraviolet radiation-induced tumor suppressor cell activity. Granstein, R.D., Parrish, J.A., McAuliffe, D.J., Waltenbaugh, C., Greene, M.I. Science (1984) [Pubmed]
  25. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. McCune, W.J., Golbus, J., Zeldes, W., Bohlke, P., Dunne, R., Fox, D.A. N. Engl. J. Med. (1988) [Pubmed]
  26. Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. Feehally, J., Beattie, T.J., Brenchley, P.E., Coupes, B.M., Houston, I.B., Mallick, N.P., Postlethwaite, R.J. N. Engl. J. Med. (1984) [Pubmed]
  27. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. Rosenberg, S.A., Packard, B.S., Aebersold, P.M., Solomon, D., Topalian, S.L., Toy, S.T., Simon, P., Lotze, M.T., Yang, J.C., Seipp, C.A. N. Engl. J. Med. (1988) [Pubmed]
  28. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. Ragaz, J., Jackson, S.M., Le, N., Plenderleith, I.H., Spinelli, J.J., Basco, V.E., Wilson, K.S., Knowling, M.A., Coppin, C.M., Paradis, M., Coldman, A.J., Olivotto, I.A. N. Engl. J. Med. (1997) [Pubmed]
  29. Cyclophosphamide inhibited B cell receptor regeneration as a basis for drug-induced tolerance;. Shand, F.L., Howard, J.G. Nature (1978) [Pubmed]
  30. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. Perry, M.C., Eaton, W.L., Propert, K.J., Ware, J.H., Zimmer, B., Chahinian, A.P., Skarin, A., Carey, R.W., Kreisman, H., Faulkner, C. N. Engl. J. Med. (1987) [Pubmed]
  31. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. Verdonck, L.F., van Putten, W.L., Hagenbeek, A., Schouten, H.C., Sonneveld, P., van Imhoff, G.W., Kluin-Nelemans, H.C., Raemaekers, J.M., van Oers, R.H., Haak, H.L. N. Engl. J. Med. (1995) [Pubmed]
  32. Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. Kotzin, B.L., Strober, S., Engleman, E.G., Calin, A., Hoppe, R.T., Kansas, G.S., Terrell, C.P., Kaplan, H.S. N. Engl. J. Med. (1981) [Pubmed]
  33. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. Curtis, R.E., Boice, J.D., Stovall, M., Bernstein, L., Greenberg, R.S., Flannery, J.T., Schwartz, A.G., Weyer, P., Moloney, W.C., Hoover, R.N. N. Engl. J. Med. (1992) [Pubmed]
  34. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. Parkman, R., Rappeport, J., Geha, R., Belli, J., Cassady, R., Levey, R., Nathan, D.G., Rosen, F.S. N. Engl. J. Med. (1978) [Pubmed]
  35. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. Lévesque, J.P., Hendy, J., Takamatsu, Y., Simmons, P.J., Bendall, L.J. J. Clin. Invest. (2003) [Pubmed]
  36. Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity. Saxton, M.L., Longo, D.L., Wetzel, H.E., Tribble, H., Alvord, W.G., Kwak, L.W., Leonard, A.S., Ullmann, C.D., Curti, B.D., Ochoa, A.C. Blood (1997) [Pubmed]
  37. Myeloid malignancies induced by alkylating agents in Nf1 mice. Mahgoub, N., Taylor, B.R., Le Beau, M.M., Gratiot, M., Carlson, K.M., Atwater, S.K., Jacks, T., Shannon, K.M. Blood (1999) [Pubmed]
  38. Recombinant human interleukin-1 receptor antagonist protects early myeloid progenitors in a murine model of cyclophosphamide-induced myelotoxicity. Chudgar, U.H., Rundus, C.H., Peterson, V.M. Blood (1995) [Pubmed]
  39. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Jounaidi, Y., Hecht, J.E., Waxman, D.J. Cancer Res. (1998) [Pubmed]
  40. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. Anasetti, C., Amos, D., Beatty, P.G., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Martin, P.J., Mickelson, E. N. Engl. J. Med. (1989) [Pubmed]
  41. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. Storb, R., Prentice, R.L., Buckner, C.D., Clift, R.A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J.A., Mason, M., Sanders, J.E., Singer, J., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D. N. Engl. J. Med. (1983) [Pubmed]
  42. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. Hauser, S.L., Dawson, D.M., Lehrich, J.R., Beal, M.F., Kevy, S.V., Propper, R.D., Mills, J.A., Weiner, H.L. N. Engl. J. Med. (1983) [Pubmed]
  43. Carcinoma of the urinary bladder after treatment with cyclophosphamide. O'Keane, J.C. N. Engl. J. Med. (1988) [Pubmed]
  44. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Lewis, E.J., Hunsicker, L.G., Lan, S.P., Rohde, R.D., Lachin, J.M. N. Engl. J. Med. (1992) [Pubmed]
WikiGenes - Universities